-
Remove1 × $80.00Quantity:
Hot
MOTS-c (10mg)
$120.00
MOTS-c is a mitochondrial-derived peptide being studied for energy regulation, endurance, and metabolic health.
Research Summary: Mitochondrial peptide studied for metabolic regulation, insulin sensitivity, and exercise performance.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Retatrutide (10mg)
$200.00
Retatrutide is a triple agonist peptide showing promise in clinical studies for advanced fat loss and metabolic health.
Research Summary: Triple agonist (GLP-1/GIP/Glucagon) studied for weight loss and glucose control. Under clinical investigation for obesity and metabolic dysfunction.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Retatrutide 20mg
$325.00
Retatrutide is a triple agonist peptide showing promise in clinical studies for advanced fat loss and metabolic health.
Research Summary: Triple agonist (GLP-1/GIP/Glucagon) studied for weight loss and glucose control. Under clinical investigation for obesity and metabolic dysfunction.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Semaglutide (5mg)
$150.00
GLP-1 receptor agonist studied in obesity and diabetes research models.
Research Summary: GLP-1 receptor agonist studied in obesity and diabetes research models.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Tirzepatide (20mg)
$250.00
Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.
Research Summary: Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.
Tirzepatide 10mg
$150.00
Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.
Research Summary: Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.
Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.